HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Ye Selected Research

asparanin A

4/2021Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Ye Research Topics

Disease

50Neoplasms (Cancer)
09/2022 - 05/2008
32Type 2 Diabetes Mellitus (MODY)
10/2022 - 02/2011
19Inflammation (Inflammations)
06/2022 - 10/2016
18Myocardial Infarction
09/2022 - 01/2007
12Infarction (Infarctions)
01/2021 - 08/2004
12Aplastic Anemia (Anemia, Hypoplastic)
12/2020 - 11/2011
9Neoplasm Metastasis (Metastasis)
12/2021 - 12/2013
8Infections
02/2022 - 01/2015
8Fibrosis (Cirrhosis)
11/2021 - 01/2015
7Heart Failure
01/2021 - 01/2010
6Glioma (Gliomas)
02/2022 - 02/2018
6Hypoglycemia (Reactive Hypoglycemia)
12/2021 - 01/2017
6Endometrial Neoplasms (Endometrial Cancer)
04/2021 - 09/2017
6Hypoxia (Hypoxemia)
01/2021 - 12/2009
6Insulin Resistance
01/2021 - 09/2006
6Shock
08/2020 - 01/2019
5Ischemia
09/2022 - 06/2004
5Fatigue
01/2022 - 04/2011
5Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 11/2008
5Liver Cirrhosis (Hepatic Cirrhosis)
11/2020 - 01/2015
5Stomach Neoplasms (Stomach Cancer)
10/2020 - 01/2013
5Graves Ophthalmopathy
12/2019 - 06/2014
5Dry Eye Syndromes (Dry Eye Syndrome)
01/2019 - 01/2017
4Rheumatoid Arthritis
02/2022 - 01/2021
4Pain (Aches)
01/2022 - 01/2017
4Reperfusion Injury
12/2021 - 12/2009
4Hemolysis
10/2021 - 02/2016
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2021 - 01/2018
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2015
4Thrombosis (Thrombus)
12/2020 - 10/2007
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 07/2012
4Colitis
11/2019 - 01/2018
4Body Weight (Weight, Body)
11/2016 - 02/2011
4Carcinoid Tumor (Carcinoid)
08/2010 - 05/2005
3Myocardial Ischemia (Ischemic Heart Diseases)
09/2022 - 01/2017
3Atherosclerosis
09/2022 - 10/2006
3Glioblastoma (Glioblastoma Multiforme)
05/2022 - 01/2020
3Prostatic Neoplasms (Prostate Cancer)
02/2022 - 01/2016
3Adenocarcinoma
01/2022 - 01/2017
3Hyperplasia
01/2022 - 01/2016
3Adenoma (Adenomas)
01/2022 - 01/2016
3Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2022 - 01/2021
3Residual Neoplasm
01/2022 - 01/2018
3Breast Neoplasms (Breast Cancer)
12/2021 - 11/2016
3Brain Injuries (Brain Injury)
12/2021 - 06/2009
3Papillary Thyroid Cancer
11/2021 - 11/2009
3Lymphatic Metastasis
11/2021 - 08/2014
3Hepatocellular Carcinoma (Hepatoma)
09/2021 - 01/2016
3Cerebral Hemorrhage
04/2021 - 10/2018
3Necrosis
01/2021 - 02/2018
3medullary Thyroid cancer
01/2021 - 05/2008
3Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2020 - 12/2009
3Ovarian Neoplasms (Ovarian Cancer)
04/2020 - 01/2016

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2013
20Insulin (Novolin)FDA Link
01/2021 - 09/2006
15Biomarkers (Surrogate Marker)IBA
02/2022 - 07/2015
14Glucose (Dextrose)FDA LinkGeneric
12/2021 - 02/2011
11Pharmaceutical PreparationsIBA
05/2022 - 11/2012
11Blood Glucose (Blood Sugar)IBA
02/2022 - 09/2006
9Biological ProductsIBA
01/2021 - 12/2009
7CytokinesIBA
06/2022 - 09/2012
7Ophthalmic Solutions (Eye Drops)IBA
12/2018 - 01/2017
6Messenger RNA (mRNA)IBA
06/2022 - 01/2016
6Therapeutic UsesIBA
06/2022 - 01/2017
6Hormones (Hormone)IBA
01/2022 - 12/2009
6MicroRNAs (MicroRNA)IBA
04/2021 - 12/2013
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 06/2004
6Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2020 - 11/2007
5Indicators and Reagents (Reagents)IBA
01/2022 - 08/2013
5Adrenocorticotropic Hormone (ACTH)FDA Link
12/2021 - 04/2008
5Small Interfering RNA (siRNA)IBA
11/2020 - 04/2009
4GLPG0634IBA
02/2022 - 01/2021
4LipidsIBA
01/2022 - 10/2016
4AntibodiesIBA
01/2021 - 01/2016
4AntigensIBA
01/2021 - 01/2015
4FibrinIBA
01/2021 - 08/2012
4Hemoglobins (Hemoglobin)IBA
03/2020 - 09/2006
4Dextran SulfateIBA
11/2019 - 01/2018
4Tyrosine Kinase InhibitorsIBA
04/2019 - 09/2009
4Phosphotransferases (Kinase)IBA
01/2019 - 05/2008
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2008
4AdiponectinIBA
11/2015 - 10/2006
3Methotrexate (Mexate)FDA LinkGeneric
02/2022 - 01/2021
3AndrogensIBA
02/2022 - 12/2020
3AldosteroneIBA
01/2022 - 02/2012
3SteroidsIBA
01/2022 - 12/2015
3Hydrocortisone (Cortisol)FDA LinkGeneric
12/2021 - 03/2019
3IronIBA
11/2021 - 06/2014
3LectinsIBA
04/2021 - 01/2020
3EnzymesIBA
01/2021 - 01/2020
3CreatinineIBA
01/2021 - 03/2015
3CateninsIBA
01/2021 - 01/2018
3Immunoglobulin G (IgG)IBA
12/2020 - 01/2016
3AcidsIBA
01/2020 - 05/2017

Therapy/Procedure

55Therapeutics
06/2022 - 10/2007
12Transplantation
01/2021 - 05/2007
7Lasers (Laser)
10/2020 - 01/2019
6Immunotherapy
02/2022 - 01/2016
6Glycemic Control
01/2021 - 04/2015
4Drug Therapy (Chemotherapy)
12/2021 - 07/2018